2022
DOI: 10.34071/jmp.2022.1.14
|View full text |Cite
|
Sign up to set email alerts
|

A Study on Dialysate Glucose Concentration in Patients With Continuous Ambulatory Peritoneal Dialysis

Abstract: Background: Glucose-based peritoneal dialysis (PD) is the predominantly used dialysate in PD patients. Glucose absorption in peritoneal dialysis (PD) patients may contribute to adverse metabolic complications. The impact of high peritoneal dialysate glucose concentration (PDGC) on all-cause as well as cardiovascular disease (CVD) mortality in peritoneal dialysis (PD) patients is unclear. The current researchs widely applied formulae may be not suitable for estimation of glucose absorption in continuous ambulat… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles